Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy
- Type
- Retraction
- Notice date
- 8/9/2021 0:00
- Journal
- npj Precision Oncology
- Publisher
- Springer - Nature Publishing Group
- Notice DOI
- 10.1038/s41698-021-00217-9
- Original paper DOI
- 10.1038/s41698-017-0008-z